News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

OccuLogix Inc. (RHEO) Enters Into Definitive Agreement To Acquire SOLX



8/1/2006 2:42:39 PM

OccuLogix, Inc. (NASDAQ: RHEO)(TSX: RHE) today announced that it has signed a definitive merger agreement to acquire SOLX, Inc. ("SOLX") pursuant to the Company's previously announced diversification plans focusing on age-related eye diseases. Based at the world renowned Boston University Photonics Center in Boston, Massachusetts, SOLX is a privately held company developing novel approaches to the treatment of glaucoma.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES